HansBiomed Corporation (042520) — Cash Flow Reinvestment Rate
HansBiomed Corporation (042520) has a Cash Flow Reinvestment Rate of 0.37x as of September 2025, reinvesting ₩448.85 Million (capex ₩448.85 Million ) from operating cash flow of ₩1.21 Billion. Explore HansBiomed Corporation capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HansBiomed Corporation Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for HansBiomed Corporation across 10 annual periods. Also explore 042520 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for HansBiomed Corporation (2012–2025)
Year-by-year capital reinvestment analysis for HansBiomed Corporation. For live market cap and broader valuation context, see HansBiomed Corporation (042520) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 5.58x | ₩1.78 Billion | ₩318.34 Million | ₩1.76 Billion | ▲ +4.2% |
| 2024 | 5.36x | ₩9.42 Billion | ₩1.76 Billion | ₩2.83 Billion | ▲ +127.0% |
| 2020 | 2.36x | ₩13.57 Billion | ₩5.75 Billion | ₩7.05 Billion | ▼ -19.2% |
| 2019 | 2.92x | ₩22.54 Billion | ₩7.71 Billion | ₩15.56 Billion | ▲ +282.6% |
| 2018 | 0.76x | ₩3.97 Billion | ₩5.20 Billion | ₩2.24 Billion | ▼ -67.7% |
| 2017 | 2.37x | ₩13.24 Billion | ₩5.60 Billion | ₩13.05 Billion | ▲ +30.9% |
| 2015 | 1.81x | ₩6.26 Billion | ₩3.47 Billion | ₩6.07 Billion | ▼ -72.1% |
| 2014 | 6.47x | ₩13.35 Billion | ₩2.06 Billion | ₩12.39 Billion | ▲ +107.1% |
| 2013 | 3.13x | ₩7.29 Billion | ₩2.33 Billion | ₩7.29 Billion | ▲ +1750.5% |
| 2012 | 0.17x | ₩253.56 Million | ₩1.50 Billion | ₩253.56 Million | — |